INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2 DOMAIN Read more about INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2 DOMAIN Canada2387922Filed on 2000-10-20
INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN Read more about INHIBITION OF CELL MOTILITY AND ANGIOGENESIS BY INHIBITORS OF THE GRB2 SH2-DOMAIN Australia29166/01Filed on 2000-10-20
Layered Device with Capture Regions For Cellular Analysis Read more about Layered Device with Capture Regions For Cellular Analysis Japan2001-512292Filed on 2000-07-26
Methods for Treating Tumors Using Antiangiogenic Compounds Read more about Methods for Treating Tumors Using Antiangiogenic Compounds Canada2372699Filed on 2000-05-05
Methods for Treating Tumors Using Antiangiogenic Compounds Read more about Methods for Treating Tumors Using Antiangiogenic Compounds Australia48249/00Filed on 2000-05-05
Tumor Cell Toxicity of a Novel Metal Chelator Read more about Tumor Cell Toxicity of a Novel Metal Chelator Japan2000-536699Filed on 1999-03-18
DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS Read more about DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS Canada2321307Filed on 1999-02-24
DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS Read more about DISUBSTITUTED LAVENDUSTIN A ANALOGS AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANALOGS Australia29736/99Filed on 1999-02-24